ALEXANDRIA, Va., April 9 -- United States Patent no. 12,269,883, issued on April 8, was assigned to Mozart Therapeutics Inc (Seattle).
"Binding agents and methods of using the same" was invented by Courtney Crane (Seattle), Kristine Swiderek (Seattle) and Susan Julien (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides binding agents that specifically bind to CD8+KIR+ T regulatory cells and their use in the treatment of diseases or disorders, such as an inflammatory disease, an autoimmune disease, cancer, or an infectious disease."
The patent was filed on Oct. 4, 2024, under Application No. 18/907,087.
*For further information, including images, charts and tables, please ...